PROUD Study - Preventing Opioid Use Disorders

• Status: Recruiting
• Trial end date: 2021-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to pilot an opioid free anesthetic protocol for patients undergoing total hip replacement.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Emory University
• Treatments: Acetaminophen; Aspirin; Bupivacaine; Diclofenac; Ketorolac Tromethamine; Lidocaine; Meloxicam; Omeprazole; Prednisone; Pregabalin; Propofol; Tramadol; Tranexamic Acid

Criteria

Inclusion Criteria:

Intervention group:

• Prospective study participants undergoing unilateral total hip replacement surgery between the months of February - May 2021

Control:

• Retrospective controls selected from the Emory Healthcare System Clinical Data Warehouse that underwent unilateral total hip replacement surgery between the months of February - May 2020

Professional Staff:

• All staff that participate in the implementation of the opioid free surgical protocol.

Exclusion Criteria:

• Participants that do not speak English will not be eligible for participation in the study.

• Individuals less than 18 years of age will not be included for participation in the study.

• Individuals with cognitive impairment or the inability to provide informed consent will not be included in the study.